Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: Comparable survival and recurrence

Liver Transplantation

Volumn 18, Issue 3, 2012, Pages 315-322

  Sandhu, Lakhbir ^a   Sandroussi, Charbel ^a   Guba, Markus ^a   Selzner, Markus ^a   Ghanekar, Anand ^a   Cattral, Mark S ^a   McGilvray, Ian D ^a   Levy, Gary ^a   Greig, Paul D ^a   Renner, Eberhard L ^a   Grant, David R ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DECEASED DONOR LIVER TRANSPLANTATION; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REGRESSION ANALYSIS; SURVIVAL RATE;

EID: 84857571819     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22477     Document Type: Article

References (31)

1. World Health Organization. Mortality data. Accessed November 2011.
2. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R,. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985; 1: 1357-1360. (Pubitemid 15060907)
3. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al.; for Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
4. Shah SA, Cleary SP, Tan JC, Wei AC, Gallinger S, Grant DR, Greig PD,. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol 2007; 14: 2608-2614. (Pubitemid 47389575)
5. Evans RW,. The actual and potential supply of organ donors in the United States. Clin Transpl 1990: 329-341.
6. Kulik L, Abecassis M,. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127 (suppl 1): S277-S282. (Pubitemid 39423397)
7. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J,. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78-86. (Pubitemid 46142736)
8. Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al.; for A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7: 1601-1608. (Pubitemid 46776250)
9. Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, et al. Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 2009; 15: 1861-1866.
10. Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y,. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 1998; 124: 57-64. (Pubitemid 28354686)
11. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8: 873-883. (Pubitemid 35154015)
12. Di Sandro S, Slim AO, Giacomoni A, Lauterio A, Mangoni I, Aseni P, et al. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant Proc 2009; 41: 1283-1285.
13. Bruix J, Sherman M,; for Practice Guidelines Committee of American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236. (Pubitemid 43112690)
14. DuBay D, Sandroussi C, Sandhu L, Cleary S, Guba M, Cattral MS, et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg 2011; 253: 166-172.
15. Adcock L, Macleod C, Dubay D, Greig PD, Cattral MS, McGilvray I, et al. Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience. Am J Transplant 2010; 10: 364-371.
16. Sandroussi C, Dawson LA, Lee M, Guindi M, Fischer S, Ghanekar A, et al. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma. Transpl Int 2010; 23: 299-306.
17. Cattral MS, Molinari M, Vollmer CM Jr, McGilvray I, Wei A, Walsh M, et al. Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patients. Am J Transplant 2004; 4: 751-757. (Pubitemid 38637573)
18. Edmondson HA, Steiner PE,. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
19. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
20. Cox DR,. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
21. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
22. Xu X, Ke QH, Shao ZX, Wu J, Chen J, Zhou L, Zheng SS,. The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci 2009; 54: 385-388.
23. Mailey B, Artinyan A, Khalili J, Denitz J, Sanchez-Luege N, Sun CL, et al. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer. Arch Surg 2011; 146: 26-33.
24. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG,. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005; 11: 1265-1272. (Pubitemid 41511942)
25. Todo S, Furukawa H; for Japanese Study Group on Organ Transplantation,. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-459.
26. Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008; 14: 935-945. (Pubitemid 352003892)
27. Concejero A, Chen CL, Wang CC, Wang SH, Lin CC, Liu YW, et al. Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan. Transplantation 2008; 85: 398-406. (Pubitemid 351322764)
28. Axelrod D, Koffron A, Kulik L, Al-Saden P, Mulcahy M, Baker T, et al. Living donor liver transplant for malignancy. Transplantation 2005; 79: 363-366. (Pubitemid 40299547)
29. Gondolesi GE, Roayaie S, Muñoz L, Kim-Schluger L, Schiano T, Fishbein TM, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004; 239: 142-149. (Pubitemid 38176346)
30. Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 2003; 75 (suppl): S37-S40. (Pubitemid 36222987)
31. Malagõ M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, et al. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl 2006; 12: 934-940. (Pubitemid 43960369)